Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Advanced Technologies obtains United States patent.


Advanced Technologies (Cambridge) Limited (London, England) has patented a method for isolating and characterizing of novel expansin gene sequences from heterologous heterologous /het·er·ol·o·gous/ (het?er-ol´ah-gus)
1. made up of tissue not normal to the part.

2. xenogeneic.


het·er·ol·o·gous
adj.
1.
 and homologous homologous /ho·mol·o·gous/ (ho-mol´ah-gus)
1. corresponding in structure, position, origin, etc.

2. allogeneic.


ho·mol·o·gous
adj.
1.
 tree species and re-introducing such novel genes into trees so as to alter expansin levels. Six novel genes have been identified. Eucalyptus has also been transformed using the cucumber EX29 sequence (GenBank, Accession No. U30382-known as Cs-EXP1) (SEQ SEQ Sequence
SEQ Sequential
SEQ South East Queensland (Australia)
SEQ Smart Equities Conference
SEQ Sequens/Sequentes
SEQ Senior Enlisted Quarters
SEQ Short Essay Question
SEQ Stigmatisation and Eczema Questionnaire
SEQ Scientific Equipment
. ID. NO: 9). A change in the plant height and internode in·ter·node
n.
1. A section or part between two nodes.

2. An internodal segment.



in
 length was observed compared with control plants. (US 7,002,059)
COPYRIGHT 2006 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Geographic Code:1USA
Date:Jan 1, 2006
Words:83
Previous Article:du Pont obtains United States patent.
Next Article:AMRAD obtains United States patent.
Topics:



Related Articles
Aurora announces issuance of second patent on fluorescence assay technology.
Oxford announces grant of expanded high-throughput proteomics patent.
TKT announces issuance of two gene therapy patents.
Lorus Therapeutics patents to protect lead anticancer target.
Roche's Taq patent held unenforceable for inequitable conduct.
Federal Court of Appeals to decide on claims for United States in fraud case against Hoffmann-La Roche.
Lexicon granted exclusive license to Cellectis' homologous recombination technology.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles